These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17255262)

  • 21. Preoperative positron emission tomography with fluorine-18-fluorodeoxyglucose is predictive of prognosis in patients with hepatocellular carcinoma after resection.
    Hatano E; Ikai I; Higashi T; Teramukai S; Torizuka T; Saga T; Fujii H; Shimahara Y
    World J Surg; 2006 Sep; 30(9):1736-41. PubMed ID: 16850145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma.
    Trojan J; Schroeder O; Raedle J; Baum RP; Herrmann G; Jacobi V; Zeuzem S
    Am J Gastroenterol; 1999 Nov; 94(11):3314-9. PubMed ID: 10566736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of Id proteins in human hepatocellular carcinoma: relevance to tumor dedifferentiation.
    Damdinsuren B; Nagano H; Kondo M; Yamamoto H; Hiraoka N; Yamamoto T; Marubashi S; Miyamoto A; Umeshita K; Dono K; Nakamori S; Wakasa K; Sakon M; Monden M
    Int J Oncol; 2005 Feb; 26(2):319-27. PubMed ID: 15645115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Positron emission tomography with fluorine-18-fluorodeoxyglucose is useful for predicting the prognosis of patients with hepatocellular carcinoma].
    Kong YH; Han CJ; Lee SD; Sohn WS; Kim MJ; Ki SS; Kim J; Jeong SH; Kim YC; Lee JO; Cheon GJ; Choi CW; Lim SM
    Korean J Hepatol; 2004 Dec; 10(4):279-87. PubMed ID: 15613803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 18F-fluorodeoxyglucose uptake on positron emission tomography as a prognostic predictor in locally advanced hepatocellular carcinoma.
    Kim BK; Kang WJ; Kim JK; Seong J; Park JY; Kim DY; Ahn SH; Lee DY; Lee KH; Lee JD; Han KH
    Cancer; 2011 Oct; 117(20):4779-87. PubMed ID: 21469082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of hepatocellular carcinoma with PET/CT: a prospective comparison of 18F-fluorocholine and 18F-FDG in patients with cirrhosis or chronic liver disease.
    Talbot JN; Fartoux L; Balogova S; Nataf V; Kerrou K; Gutman F; Huchet V; Ancel D; Grange JD; Rosmorduc O
    J Nucl Med; 2010 Nov; 51(11):1699-706. PubMed ID: 20956466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of hepatocellular carcinoma using 11C-choline PET: comparison with 18F-FDG PET.
    Yamamoto Y; Nishiyama Y; Kameyama R; Okano K; Kashiwagi H; Deguchi A; Kaji M; Ohkawa M
    J Nucl Med; 2008 Aug; 49(8):1245-8. PubMed ID: 18632827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of FDG-PET in the evaluation and staging of hepatocellular carcinoma with comparison of tumor size, AFP level, and histologic grade.
    Wolfort RM; Papillion PW; Turnage RH; Lillien DL; Ramaswamy MR; Zibari GB
    Int Surg; 2010; 95(1):67-75. PubMed ID: 20480845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. X-linked inhibitor of apoptosis (XIAP) and XIAP-associated factor-1 expressions and their relationship to apoptosis in human hepatocellular carcinoma and non-cancerous liver tissues.
    Sakemi R; Yano H; Ogasawara S; Akiba J; Nakashima O; Fukahori S; Sata M; Kojiro M
    Oncol Rep; 2007 Jul; 18(1):65-70. PubMed ID: 17549347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FDG PET/CT early dynamic blood flow and late standardized uptake value determination in hepatocellular carcinoma.
    Bernstine H; Braun M; Yefremov N; Lamash Y; Carmi R; Stern D; Steinmetz A; Sosna J; Groshar D
    Radiology; 2011 Aug; 260(2):503-10. PubMed ID: 21555347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The significance of FDG uptake in bilateral thyroid glands.
    Chen YK; Chen YL; Cheng RH; Yeh CL; Lee CC; Hsu CH
    Nucl Med Commun; 2007 Feb; 28(2):117-22. PubMed ID: 17198352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proposal of a New Preoperative Prognostic Model for Solitary Hepatocellular Carcinoma Incorporating
    Yoh T; Seo S; Ogiso S; Kawai T; Okuda Y; Ishii T; Taura K; Higashi T; Nakamoto Y; Hatano E; Kaido T; Uemoto S
    Ann Surg Oncol; 2018 Feb; 25(2):542-549. PubMed ID: 29168098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 18F-Fluorodeoxyglucose uptake on positron emission tomography/computed tomography is associated with metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma.
    Lee M; Jeon JY; Neugent ML; Kim JW; Yun M
    Clin Exp Metastasis; 2017 Apr; 34(3-4):251-260. PubMed ID: 28429188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased levels of tissue inhibitor of metalloproteinase-1 in human hepatocellular carcinoma.
    Matsumoto E; Nakatsukasa H; Nouso K; Kobayashi Y; Nakamura S; Suzuki M; Takuma Y; Tanaka H; Fujikawa T; Shiratori Y
    Liver Int; 2004 Aug; 24(4):379-83. PubMed ID: 15287862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of Keratin 19-Positive Cancer Stem Cells Associating Human Hepatocellular Carcinoma Using
    Kawai T; Yasuchika K; Seo S; Higashi T; Ishii T; Miyauchi Y; Kojima H; Yamaoka R; Katayama H; Yoshitoshi EY; Ogiso S; Kita S; Yasuda K; Fukumitsu K; Nakamoto Y; Hatano E; Uemoto S
    Clin Cancer Res; 2017 Mar; 23(6):1450-1460. PubMed ID: 27663597
    [No Abstract]   [Full Text] [Related]  

  • 36. The status of Fas and Fas ligand expression can predict recurrence of hepatocellular carcinoma.
    Ito Y; Monden M; Takeda T; Eguchi H; Umeshita K; Nagano H; Nakamori S; Dono K; Sakon M; Nakamura M; Tsujimoto M; Nakahara M; Nakao K; Yokosaki Y; Matsuura N
    Br J Cancer; 2000 Mar; 82(6):1211-7. PubMed ID: 10735508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined early dynamic
    Zhang Y; Dong Y; Yu W; Chen S; Yu H; Li B; Shi H
    Abdom Radiol (NY); 2023 Oct; 48(10):3127-3134. PubMed ID: 37439840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FDG-PET predicted unfavorable tumor histology in living donor liver transplant recipients; a retrospective cohort study.
    Ling LL; Hsu CC; Yong CC; Elsarawy AM; Chan YC; Wang CC; Li WF; Lin TL; Kuo FY; Cheng YF; Lin LM; Chen CL; Lin CC
    Int J Surg; 2019 Sep; 69():124-131. PubMed ID: 31386913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathological implications of immunohistochemically demonstrated mucin core protein expression in hepatocellular carcinoma.
    Ichikawa T; Yamamoto T; Uenishi T; Tanaka H; Takemura S; Ogawa M; Tanaka S; Suehiro S; Hirohashi K; Kubo S
    J Hepatobiliary Pancreat Surg; 2006; 13(3):245-51. PubMed ID: 16708303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of vascular endothelial growth factor receptors is closely related to the histological grade of hepatocellular carcinoma.
    Amaoka N; Saio M; Nonaka K; Imai H; Tomita H; Sakashita F; Takahashi T; Sugiyama Y; Takami T; Adachi Y
    Oncol Rep; 2006 Jul; 16(1):3-10. PubMed ID: 16786116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.